SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma [clinicaltrials:NCT00288379]

Bio2RDF uri

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma [clinicaltrials:NCT00288379]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00288379

Bio2RDF identifier

NCT00288379

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00288379

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00288379

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:622caf56b633089ea886f65319748980

brief summary [clinicaltrials_vocabulary:brief-summary]

To compare the effects ...... tients with mild asthma

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

SMILDA - Symbicort®Turbuhaler® ...... rgic Patients With Mild Asthma

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:019867eb5bb2b74e4d70d0dc4706d83e]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:17e6c4fa223c08efb0ffc37b0203df0a]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:48b426950629b50cae85c85b1be702e9]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:6cd92af392d089c0d813980b82f68f18]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:b005787551ef9be04ae0a871c6989214]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:b6e9d0fc642bbe1a721bc91af3c5b6f4]

PD20 methacholine (measured as the change using the measurement before and after each treatment period). [clinicaltrials_resource:b9ea1964893f3d5b467a34fc9f921a83]

completion date [clinicaltrials_vocabulary:completion-date]

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00288379 [clinicaltrials_resource:df87a0a2a59a26dc796fc35ba1f66419]

enrollment [clinicaltrials_vocabulary:enrollment]

http://www.w3.org/2001/XMLSchema#integer

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2006-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

formoterol [clinicaltrials_resource:d0ad9a4d07affedf1bb630744180e698]

budesonide/formoterol [clinicaltrials_resource:f3fd75589f43b9726022a3a2b631b17a]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Budesonide [clinicaltrials_resource:34e2248d22a3c3f6fa3e2376fb9a4b50]

Symbicort [clinicaltrials_resource:4872caa847c2fdf5c94cb04d57d4de6a]

Formoterol [clinicaltrials_resource:7c9974a4b99030777b15c6c12159d4ac]

keyword [clinicaltrials_vocabulary:keyword]

Asthma

http://www.w3.org/2001/XMLSchema#string

Symbicort®

http://www.w3.org/2001/XMLSchema#string

airway inflammation

http://www.w3.org/2001/XMLSchema#string

airway responsiveness

http://www.w3.org/2001/XMLSchema#string

allergen challenge

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2011-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

AstraZeneca [clinicaltrials_resource:a083735aebc9a325683091959d090667]

location [clinicaltrials_vocabulary:location]

Research Site [clinicaltrials_resource:8c1a4471801f996db4ef663d1af34b8c]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00288379

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

A Comparative, Placebo-control ...... rgic Patients With Mild Asthma

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

D5890L00007

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

AstraZeneca Symbicort Medical Science Director, MD [clinicaltrials_resource:4825f68f289a1de07395cc98cc239d13]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Sweden: Medical Products Agency [clinicaltrials_resource:7c21b30b49d2d7f3e344daca0730fae9]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

secondary id [clinicaltrials_vocabulary:secondary-id]

EudraCT No 2004-000211-26

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

AstraZeneca [clinicaltrials_resource:a083735aebc9a325683091959d090667]

start date [clinicaltrials_vocabulary:start-date]

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00288379 study design [clinicaltrials_resource:87ecd847c8570083f96be06ad0ab0423]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00288379

verification date [clinicaltrials_vocabulary:verification-date]

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00288379

http://www.w3.org/2001/XMLSchema#string

title

SMILDA - Symbicort®Turbuhaler® ...... rgic Patients With Mild Asthma

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

SMILDA - Symbicort®Turbuhaler® ...... a [clinicaltrials:NCT00288379]

@en